Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Abstract Text:

Arnljot Tveit,Ingebjørg Seljeflot,Irene Grundvold,Michael Abdelnoor,Pal Smith,Harald Arnesen,

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Publishing Authors By Initials

A Tveit,I Seljeflot,I Grundvold,M Abdelnoor,P Smith,H Arnesen,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Thrombosis research

VOLUME: 121

Page Numbers: 447-53

Journal Abbreviation: Thromb. Res.

ISSN: 0049-3848

DAY: 14

MONTH: 08

YEAR: 2007

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 326377

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.

AFFILIATION: Department of Internal Medicine, Asker and Baerum Hospital, Norway.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Thromb Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation Related Publications

• Adrenocortical lipid depletion and leukemia in mice.
• Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study.
• Change in serum lipids and body mass index by age, sex, and smoking status: the Tromsø study 1986-1995.
• Comments on the treatment of strangulated hernias.
• Fibrinogen degradation products and fibrinogen to fibrin conversion.
• Fracture of the os calcis and its treatment. II. A contribution to the discussion on the treatment of calcaneus fracture based on an analysis of a ten-year material treated by closed reduction and traction, from Sentralsykehuset i Trondheim.
• Glandular structures in the thymus of mice.
• Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction.
• Isoelectric focusing of fibrinogen degradation products.
• Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.
• Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease.
• Numerical estimations of structures in the cochlear nuclei and cochlear afferents and efferents.
• Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
• Proliferations of the retinal pigment epithelium.
• Speech rehabilitation in laryngectomees with tracheo-oesophageal fistulas and prostheses.
• The adrenothymic constitution and susceptibility to leukemia in mice; a study of the AKR/O and WLO strains and their hybrids.
• [Biopsy]
• [Fibrinolytic therapy of venous thrombosis]
• [Fibrinolytic treatment of pulmonary embolism]
• [Functional hyperaldosteronism]
• [Inflammatory processes. Structural, functional and therapeutic aspects. Introduction and definition]
• [Mouse leukemia.]
• [Not Available.]
• [Not Available.]
• [Oral anticoagulation--a good prophylaxis requiring check up]
• [Organ changes in hypertension from the pathologico-anatomic point of view. The retina and the choroid]
• [Present situation of fibrinolytic therapy]
• [Secondary prophylaxis after myocardial infarction, bypass surgery and percutaneous coronary intervention]
• [Tonsillectomy à chaud in the presence of peritonsillar abscess]
• [Why dissections?]